15 + 13 =

Head Office

Clinical and Regulatory Departments
2 Rue Briçonnet
F-30 000 Nîmes

Grenoble Office

Administration & Pharmaceutical
Innovallée
445 Rue Lavoisier – Bât A
F-38 330 Montbonnot

Paris Office

22 Rue de la Paix – 3ème étage
F-75002 Paris

 

General inquiries : contact@advicenne.com
Investors : investors@advicenne.com

Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.

Contact Us

6 + 15 =

© 2019 Advicenne